Thorotrast induced hepatic cholangiocarcinoma and angiosarcoma.

Hum Pathol, 1979/1;10(1):108-12.

Winberg CD, Ranchod M

PMID: 218882

Impact factor: 3.526

Abstract
A 49 year old woman developed hepatic cholangiocarcinoma and angiosarcoma 22 years after the administration of Thorotrast. The etiologic association between Thorotrast and a variety of malignant hepatic neoplasms is well known, but the simultaneous occurrence of two different hepatic neoplasms has not been previously reported.
MeSH terms
More resources
EndNote: Download